CVS Health Corporation

CVS Healthcare Healthcare Plans

CVS Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $402.1 billion, up 7.85% from fiscal 2024. In the quarter to June 2026, revenue grew 7.26%, EPS grew 187.7%, free cash flow grew 338.3% and total debt fell 7.64%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten.

87.65 0.09 −0.10%
Market cap
$112.2B
P/E
22.9×
Fwd P/E
15.4×
Dividend yield
3.79%
F-score
7/9
Altman Z
2.26
Beneish M
−2.64
Dividend safety
43/100
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
27.01 31.09 56.28 188.48

+8 more quarters

P/S ratio
0.32 0.22 0.25 0.24
P/FCF ratio
11.25 12.37 12.88 15.20
P/Operating CF
20.85 21.52 29.66 120.19
P/B ratio
1.66 1.18 1.33 1.31
EV/Sales
0.43 0.35 0.38 0.38
EV/EBITDA
9.70 8.78 10.31 9.86
EV/FCF
15.29 19.30 19.79 23.88
Current Ratio
0.87 0.87 0.84 0.83
Net Debt/EBITDA
8.14 8.85 16.56 14.95
Debt/Equity
0.77 0.81 0.86 0.90
Earnings Yield
3.70% 3.22% 1.78% 0.53%
Free Cash Flow Yield
8.89% 8.09% 7.76% 6.58%
Free Cash Flow per Share
4.42 2.67 2.06 0.08
Book value per Share
62.47 60.99 59.50 57.61
Free Cash Flow
5,654.00 3,400.00 2,606.00 98.00
EV/EBIT
21.69 23.92 33.16 30.57
Other line items

Show all line items

Columns are period end dates